Поиск партнера

Spanish Research Group on Respiratory Diseases of North Barcelona, member of Ciberes Network (http://www.ciberes.org/ ), interested in participating in topic SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease.

В случае заинтересованности, обращайтесь в НКТ.

A bioinformatic SME from Germany is searching for SME partners for a project in the EuroTransBio 12th transnat. call on method allowing to use next-generation sequencing and high throughput binding data of combinatorial selection procedures used for the development of new biologics to predict optimized biological lead structures, incl. new algorithms. The partner should perform selections for new biologics, provide enriched libraries for sequencing, and perform functional tests with candidates.

A French-based consortium is preparing a proposal for the Horizon 2020 SC1-PM-16-2017 call: “In-silico trials for developing and assessing biomedical products”. The project is to propose a novel 3D-digital and physiological model of the liver perfusion, capable of simulating the injection of a drug and its impact upon healthy tissues and hepatic lesions. The research team is looking for private or public partners in economics and public health to evaluate the project’s economic impacts.

Университет из Боснии и Герцеговины ищет партнеров для подачи заявки на конкурс Горизонт 2020 SC1-PM-07-2017: Promoting mental health and well-being in the young.

По вопросам сотрудничества обращаться в адрес НКТ "Здравоохранение" mail@fp7-health.ru.

A toxin group of a UK research organisation specialising in public health seeks research partners for topic IMI2-2016-09-01 proposal. The project focus is to address the clinical burden of clostridium difficile infection (CDI) including evaluation of the burden, current practices and set-up of a European research platform. Partners sought are research institutions, SMEs and academia with relevant active research/expertise or capabilities to support the project.

A Spanish SME (already a beneficiary from SME instrument phase 1) is willing to submit a project proposal within the phase 2 SMEInst-06: (Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well). The project aims to develop an optimized computational platform for personalized medicine purposes. Hospitals with expertise in the field of functional genomics and personalized medicine are being sought. Call deadline 15/06/16

A small business from Germany active in the field of biotechnology is looking for partners for the Call "Comparing the effectiveness of existing healthcare interventions in the adult population", SC1-PM-10-2017 in Horizon 2020. The company would like to head the consortium.

Spanish university is seeking an industrial partner interested in being part of a proposal in the H2020 programme, topic SC1-PM-06-2016 "Vaccine development for malaria and/or neglected infectious diseases". The partner sought will lead the production of the pathogen and its inactivation in the scale of hundreds of litres in order to manufacture the clinical lots. It shall be authorised for Biosafety Level 2 (BSL2 or P2)

A Greek university with expertise in immunology and cancer research, is preparing a proposal for H2020 call topic SC1-PM-09–2016: New therapies for chronic diseases, in order to investigate the prognostic role of distinct small ribonucleotides (microRNAs), in lung carcinogenesis and their association with immune Tumor Infiltrating Lymphocytes (TILs). They are searching for a research organization and/or university with expertise in lung carcinogenesis as well as a hospital for clinical trials.

The laboratory of inorganic chemistry of a Greek university, which is active in insulin mimetic activity is looking for partners to set up a proposal regarding the understanding of the molecular mechanisms of novel metallodrugs exhibiting insulinomimetic activity. They are looking for a research institute or university with expertise in metabolic syndrome research in order to submit a proposal to the call H2020-SC1-PM-09–2016: New therapies for chronic diseases.